They may also find it easier to enrol, engage, and retain patients in clinical trials that adequately accommodate their real-life needs and preferences. Improved enrolment improves trials ...
Clinical trials take a person out of that trusted environment, often in highly stressful health situations where a patient is already anxious and potentially confused or concerned. To get the best ...
The first patient has been enrolled in the phase 3 PROSTATE-IQ trial being conducted in men with prostate cancer recurrence following a prostatectomy. The first patient has been enrolled in the phase ...
What happens to a patient after I refer them to a clinical trial? Do they leave my practice? Referring patients to a clinical trial is similar to referring them to a specialist. They remain your ...
Refractory chronic cough is a cough that persists for over 8 weeks and does not respond to treatment of any underlying cause. Recent randomised trials for refractory chronic cough have shown ...
D-150 is a potential backbone therapy that is designed to provide multi-year sustained delivery of anti-VEGF (aflibercept and ...
An oncologist from Atrium Health outlines how saving time administering immunotherapy could have far-reaching benefits.
3d
Clinical Trials Arena on MSNCantargia enrols first patient in trial of nadunolimab for AML and MDSSwedish company Cantargia has enrolled the first patient in the Phase Ib/IIa trial of nadunolimab for treating individuals with acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS). This ...
Early administration of high-titre COVID-19 convalescent plasma prevents hospitalisation and death in immunocompromised ...
A clinical trial involves the study of the safety, efficacy and/or dosage regimen of a therapeutic intervention (such as a drug) in humans selected according to predetermined criteria of ...
Global Phase 3 TRANSCEND study will evaluate the efficacy and safety of felzartamab, as compared to placebo, in adults with late AMRAMR is a ...
5d
Clinical Trials Arena on MSNBiogen begins dosing in trial of felzartamab for kidney transplant patients with AMRIn Part A of the trial, subjects will be given nine intravenous infusions of either the drug or placebo over a six-month ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results